Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group.

In a large, multicenter, double-blind study of the effect of haloperidol and the atypical antipsychotic remoxipride on improvement of negative symptoms in schizophrenia, quality of life was also assessed using a modified version of the Sickness Impact Profile (SIP). Compared with previous studies, t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Awad, A G, Lapierre, Y D, Angus, C, Rylander, A
Format: Artigo
Jezik:Inglês
Izdano: 1997
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1188865/
https://ncbi.nlm.nih.gov/pubmed/9262046
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki